A B S T R A C T Cancer-free individuals from family aggregates of seemingly hereditary colon carcinoma were studied to determine the nature of their cellmediated immune capacities in mixed leukocyte culture. Members of families who demonstrated no .evidence of a precancerous condition such as polyposis coli did demonstrate substantial cellular immunopathology. Of these, 44% showed a decreased responsiveness of their peripheral mononuclear cells to allogeneic stimuli, and in a number of these individuals this deficiency clearly manifested itself as an inappropriate suppression of potentially normal lymphocyte blastogenic capacities by an adherent population of mononuclear leukocytes. This in vitro defect of recognitive immunity appears to be the same type of defect that has already been described for individuals with established malignancies. The pattem of phenotypic expression of this immunopathology within these families is not inconsistent with an hereditary disorder. Individuals from families with a known hereditary somatic precancerous condition usually did not demontrate this immunopathology. It is appropriate to speculate that the defect of recognitive immunity in the former families could be contributory to the genesis of the colon carcinoma.
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INTRODUCTION
Certain forms of cancer are doubtless hereditary. The basal cell nevus syndrome is a clear example of hereditary cutaneous cancer (1) , and approximately 40%o of all cases of retinoblastoma are hereditary (2) .
Genetic disorders which predispose to an inordinate risk of cancer include Down's syndrome (3), Fanconi's anemia (4), Bloom's syndrome (5), xeroderma pigmentosum (6) , and certain immunodeficiency diseases (7) .
Received for publication 4 June 1976 and in revised form 19January 1977. Adenocarcinoma of the colon is a most frequently occurring malignancy in the United States. Cancer of this site likewise has been shown to be related to hereditary precancerous conditions, namely familial colonic polyposis (8), Gardner's syndrome (9) , and possibly Turcot's syndrome (10) . Convincing evidence has recently accumulated, however, demonstrating that colon carcinoma can aggregate in families who show no evidence of a preexisting precancerous condition (11) (12) (13) (14) (15) . These family aggregates demonstrate an increased frequency of many histological types of adenocarcinoma, an increased frequency of multiple malignancies of the same organ, an earlier age of onset of the malignancy as compared to the general population, and an apparent vertical mode of transmission.
The purpose of the present study was to characterize the phenotypic expression of the cell-mediated immune capacities of both affected and unaffected members of family aggregates of colon carcinoma because reports are extant documenting subclinical immune defects in healthy relatives of family aggregates of lymphoproliferative disorders (16) (17) (18) and of gastric cancer (19) . We have focused attention both on lymphocyte responsiveness in mixed leukocyte culture (MLC)1 and on the modulatory role of the adherent mononuclear cell in MLC because we have previously demonstrated that some patients with various established nonlymphoid malignancies can possess apparently perturbed adherent cells which attenuate the responsiveness of their lymphocytes in MLC (20 4 Colon carcinoma family C.
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N. Berlinger, C. Lopez, M. Lipkin, J. Vogel, and R. Good G-10 beads were prepared as follows. A 10-ml glass syringe barrel, into which had been placed a plug of nylon wool large enough only to prevent leakage of the beads, was sterilized by autoclaving. After cooling, a bed volume of 6 ml of G-10 beads was placed in the upright syringe barrel. The G-10 beads had been previously allowed to swell overnight in sterile deionized water and were then boiled for 4 h for sterilization. The G-10 beads were stored in calcium-and magnesium-free phosphate buffered saline before their placement in the column. After the column was poured, the beads were washed with 30 ml of RPMI-1640 with 20% fetal calf serum. The syringe was then plugged at its outlet to prevent any further elution. The aliqtuot of FH cells was applied to the top of the column in a volume of 2.5 ml without allowing the cells to run into the bed. The column was placed in an incubator at 37°C for approximately 1 h to equilibrate. The column was then removed from the incuibator and a slurry effected by stirring all but the bottom 1 ml of the beads with a serological pipette. In this manner, the beads were allowed to settle through the aliquot of FH cells. This procedure was repeated three times, every 10 min, with the column being placed in the incubator as the beads settled. Finally, the nonadhering cells were eluted from the column with 13 method because it appears subject to the least day-to-day variation as exemplified by its small variation coefficient (26) . Further work involving the identification of human lymphocyte-activating determinants has emphasized the stability of expressing MLC results as RRs rather than as stimulation ratios (27) .
The patient's lymphocytes were allowed to respond separately to a panel of four allogeneic stimuli, and the mean response was calculated. Concurrently, four normal individuals' lymphocytes were allowed to react with the same panel, and the mean of all the normal responses to this identical panel was calculated. This latter mean response is termed the reference value (rv). The mean of the patient's responses was then expressed as a percentage of rv and is termed the relative response (RR). For all individuals tested in this study, the responses of their FH cells and of their G-10 cells were determined in MLC. RR refers to the relative response of FH cells, and RRf refers to the relative response of G-10 filtered cells.
In the various experiments, no deliberate effort was made to include the same normal individuals in the panels of responders for the generation of an rv. However, all normal individuals included were unrelated and had been previously human leukocyte antigen typed and tested in MLC to verify that a given normal panel included only combinations of individuals who were mutually strongly reactive in MLC. Satisfactory and reproducible RRs do not seem to depend on identity of normal panels from day to day but rather on the generation of rather constant rv's (26) . As can be seen from the tabular presentation of the results, this constancy had been quite well achieved in this study. 
RESULTS

Normal cell-mediated immune capacity in MLC.
A total of 51 unrelated normal individuals (31 males and 20 females) with an age range of were tested in MLC as described. Family histories of each disclosed no evidence of a familial diathesis for malignancy. The RRs of these individuals showed a range of 68-150%, with a geometric mean RR of 101% and an identical median RR of 101%. An RR less than 2 SD below this mean, namely, less than 68%, was considered to be indicative of abnormally decreased MLC responsiveness because the RRs of the normal individuals fit a log-normal distribution. All computations involved logarithmic transformations, mandated by the fact that relative values were generated.
MLC responsiveness of affected members of colon carcinoma aggregates. Repeat studies with panels of stimulating cells different than those used for the original determinations were carried out for individuals F-II-6, F-III-1, F-III-2, F-III-3, M proband, and E proband. All RRs were again normal.
Characteristics of normal RRf. In comparing tl,e RR and RRf for each of 24 normal test subjects, we have determined that these two values are seldom identical for a single individual. A more expansive analysis of this phenomenon has disclosed that the adherent cell can exert a bidirectional modulatory role in certain normal allogeneic combinations. In such cases, which are only infrequently encountered among unrelated individuals, depletion of adherent cells from the responding cell population may lead to significantly increased or decreased MLC reactivity (manuscript in preparation). In our experience, when marked changes occur they occur in no more than one of the four allogeneic combinations within a panel. This variability can result in nonidentity of the RR and RRf for normal subjects. Because RRs are geometric rather than arithmetic expressions, the logarithmic analysis of the variability of RRfs in relation to RRs is instructive. In our experience with normal individuals, the mean log change in the RRf from the RR is 0.072. This value represents <1 SD (0.085) calculated for the sample of 51 normal individuals included in this study. The mean log increase in the RRfs for the eight immunologically abnormal individuals in the family aggregates of colon carcinoma is 0.272, a value greater than 3 SD. Thus the ability to increase MLC responsiveness for these latter individuals by G-10 column filtration is significantly greater than the variability encountered with normal individuals. In our previous study of patients with established malignancies (20) , all patients demonstrated markedly increased MLC responsiveness to each of the four allogeneic stimuli when their G-10 cells were used as the responding population. In the present study, for all unaffected individuals whose MLC responses were considered deficient, adherent cell depletion likewise resulted in increased responsiveness in at least three and usually in all four allogeneic combinations, indicating a generalized hyporesponsiveness to allogeneic stimuli similar to that observed in patients Defective Immunity in Cancer Families 765 (34) frequently show impaired lymphocyte blastogenic abilities to allogeneic cells. In addition, 29% of head and neck squamous cell carcinoma patients studied in one series continued to manifest impaired cutaneous reactivity or anergy to dinitrochlorobenzene despite the fact they had remained free of disease for as long as 14 yr (35) .
Provocative, however, is the finding that, in family aggregates of colon carcinoma, 8 of 18 cancer-free individuals showed the same deficit of recognitive immunity as did their affected relatives. In this study, three individuals (P-III-1, M-IV-1, and V-IV- 1) showed RRs >5 SD below the mean of normal responsiveness, and two individuals (P-III-3 and M-IV-3) showed RRs >3 SD below the mean. The remaining three immunologically abnormal individuals (M-IV-2, C-IV-2, and J-IV-1) showed less pronounced but significantly decreased (>2 SD) (20) . Further cell marker analyses (data not shown) have revealed no significant changes in the relative proportions of Ripley positive lymphocytes or of lymphocytes which bear surface IgM employing F(ab')2 reagents, whereas alpha-naphthyl esterase positive cells are nearly completely eliminated. These data are consistent with the interpretation that the increased responsiveness of G-10 cells of these immunologically abnormal individuals is the result of the removal of suppressive adherent cells belonging to the monocyte-macrophage series. It should be emphasized that an unidentified population of adherent cells which are not macrophages, but which are co-retained with macrophages in columns of G-10 beads, could be responsible for the suppressive effect observed in MLC as a certain amount of lymphocyte loss is experienced with G-10 column filtration.
This group of patients, however, showed normal in vitro responses to common antigens and mitogens, responses which are also macrophage dependent (37) . This is not an irreconcilable dichotomy, but is reminiscent of the immunologic profile of patients with the Wiskott-Aldrich syndrome who show deficient responses in vitro to certain antigens and to allogeneic cells but are able to manifest normal lymphocyte responsiveness to nonspecific mitogens (38) . As such, our findings are discordant with those of Creagan and Fraumeni (19) who reported decreased lymphocyte blastogenesis to streptolysin-O and phytohemagglutinin in a family aggregate of gastric carcinoma.
It is interesting that none of the affected or unaffected individuals from families with familial polyposis showed any deficit of recognitive immunity, whereas the two patients with Gardner's syndrome did. These two syndromes are considered to be genetically distinct, based upon their differing phenotypic expressions (39) . Although we were able to study only two individuals with Gardner's syndrome, the possibility is tenable that a deficit of recognitive immunity may be an unsuspected component of Gardner's syndrome and could ostensibly be a reflection of the greater propensity for neoplasia in this syndrome relative to polyposis coli. The expression of defective recognitive immunity may, in fact, further serve to differentiate the various familial colonic polyposis syndromes.
Such a limited study can generate no definitive conclusions regarding a possible genetic basis for this immunologic abnormality. Nevertheless, the apparent vertical mode of transmission through two generations in the families, M, C, and G is suggestive. In addition, the number of siblings showing this immunologic abnormality in sibships of families P (3 of 3), M (3 of 6), C (1 of 2), V (1 of 2), and G (1 of 1), coupled with the finding that in two of these families the unaffected parent was immunologically normal, is not inconsistent with a dominant mode of inheritance. The possibility that this defect is secondary to some extragenetic factor is, of course, equally probable. The data generated by this study can pose the question whether a genetically transmitted immunologic determinant may be contributory to the genesis of malignancy in some of these families.
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